— Know what they know.
Not Investment Advice

ALVR NASDAQ

AlloVir, Inc.
1W: +3.4% 1M: -0.9% 3M: -7.3% 1Y: -41.3% 3Y: -94.2%
$9.81
Last traded 2025-03-18 — delisted
NASDAQ · Healthcare · Biotechnology · $49.5M mcap · 873061 float · 2.63% daily turnover · Short 30% of daily vol

Revenue Segmentation

By Product / Service

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
$0 +0.0% ▲
Operating Income
-$46M +29.5% ▲
Net Income
-$43M +26.1% ▲
EPS (Diluted)
$-2.85 +75.7% ▲
EBITDA
-$46M +29.5% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$1M$3M$398K$0$0
Gross Profit-$1M-$3M-$398K$0$0
Gross Margin—————
R&D Expenses$121M$119M$133M$12M$31M
SG&A Expenses$49M$52M$48M$43M$15M
Operating Expenses$169M$171M$181M$65M$46M
Operating Income-$170M-$171M-$181M-$65M-$46M
Operating Margin—————
Interest Expense$0$0$0$0-$1M
Income Before Tax-$171M-$169M-$191M-$59M-$43M
Tax Expense$1M-$265K-$126K$0$0
Net Income-$172M-$169M-$190M-$59M-$43M
Net Margin—————
EPS (Diluted)$-63.02$-50.60$-42.09$-11.73$-2.85
EBITDA-$170M-$166M-$190M-$65M-$46M
Shares Outstanding3M3M4M5M153M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms